Skip to Main Content

Author Details

Molly Maloy
Memorial Sloan Kettering Cancer Center
2013
93
26
PMIDPaper TitleJournal TitlePublished Year
36721042EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation.Bone Marrow Transplant2023
37422574Application of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysis.Bone Marrow Transplant2023
37009407Characteristics of Distress and Support Group Participation in Caregivers of Older Allogeneic Hematopoietic Cell Transplantation Patients: A Single Institution Retrospective Review.J Adv Pract Oncol2023
37295406High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients.Cell2023
37196646Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT.Blood Adv2023
34709102Outcomes of Patients with COVID-19 from a Specialized Cancer Care Emergency Room.Cancer Invest2022
35477992Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant.Bone Marrow Transplant2022
35506245Impact of Exercise on Susceptibility and Severity of COVID-19 in Patients with Cancer: A Retrospective Study.Cancer Epidemiol Biomarkers Prev2022
35660676Delirium in Critically Ill Cancer Patients With COVID-19.J Acad Consult Liaison Psychiatry2022
35484207CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis.Bone Marrow Transplant2022
36041227A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation.Cancer2022
35977079Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation.Blood Adv2022
35184148Ionizing radiation exposure after allogeneic hematopoietic cell transplantation.Bone Marrow Transplant2022
35142567Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation.Leuk Lymphoma2022
32555371Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin.Leukemia2021
36339371Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34<sup>+</sup>-selected allogeneic transplantation.Adv Cell Gene Ther2021
33512409Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study.Blood2021
33781518The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy.Transplant Cell Ther2021
34432870Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells.Blood Adv2021
33991721Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.Transplant Cell Ther2021
34214736Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients.Transplant Cell Ther2021
34297048Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformation.Blood Adv2021
34180767Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.Leuk Lymphoma2021
34152404Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma.Blood Adv2021
34033977Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy.Transplant Cell Ther2021
34253878The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplant.Bone Marrow Transplant2021
34135023Acute Kidney Injury in the Modern Era of Allogeneic Hematopoietic Stem Cell Transplantation.Clin J Am Soc Nephrol2021
32079691Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma.Haematologica2021
32694543Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation.Bone Marrow Transplant2021
31618690Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease.Biol Blood Marrow Transplant2020
31937928Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients.Bone Marrow Transplant2020
32088364Acute Kidney Injury after CAR-T Cell Therapy: Low Incidence and Rapid Recovery.Biol Blood Marrow Transplant2020
31935291Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin.Blood Adv2020
31756534Evaluation of Cord Blood Total Nucleated and CD34<sup>+</sup> Cell Content, Cell Dose, and 8-Allele HLA Match by Patient Ancestry.Biol Blood Marrow Transplant2020
31645667Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34<sup>+</sup> selected graft.Bone Marrow Transplant2020
32084260Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management.Blood Adv2020
32101664Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.N Engl J Med2020
31911259Incidence and Risk Factors for Acute and Chronic Kidney Injury after Adult Cord Blood Transplantation.Biol Blood Marrow Transplant2020
33290545High progression-free survival after intermediate intensity double unit cord blood transplantation in adults.Blood Adv2020
32795225Chemotherapy and COVID-19 Outcomes in Patients With Cancer.J Clin Oncol2020
32759935Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma.Blood Cancer J2020
32614964DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality.Blood Adv2020
32447045Pretransplantation Cognitive Dysfunction in Advanced-Age Hematologic Cancers: Predictors and Associated Outcomes.Biol Blood Marrow Transplant2020
32216649Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients.J Palliat Med2020
32477359The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice.Front Immunol2020
32404978Impact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma.Bone Marrow Transplant2020
32430495The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD.Blood2020
32228298The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients.Leuk Lymphoma2020
31471572Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies.Bone Marrow Transplant2020
31493537Presalvage International Staging System Stage and Other Important Outcome Associations in CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma.Biol Blood Marrow Transplant2020
  • 1 - 50 of 93

Recommended Authors

Lohith Gowda
Yale Cancer Center and Yale School of Medicine
Career Start Year 2018
Number of shared co-authors 2
Leo Ruhnke
University Hospital Dresden
Career Start Year 2018
Number of shared co-authors 0
Sawa Ito
University of Pittsburgh
Career Start Year 2013
Number of shared co-authors 0
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 0
Aarthi Shenoy
MedStar Washington Hospital Center
Career Start Year 2006
Number of shared co-authors 1
Marlise R Luskin
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 2
Geoffrey D E Cuvelier
University of Manitoba
Career Start Year 2005
Number of shared co-authors 1
Sung Won Choi
University of Michigan ann arbor
Career Start Year 2005
Number of shared co-authors 0
Tara L Lin
University of Kansas Medical Center
Career Start Year 2004
Number of shared co-authors 1
Christopher R Cogle
College of Medicine, University of Florida
Career Start Year 2003
Number of shared co-authors 0
Laura F Newell
Oregon Health and Science University
Career Start Year 2003
Number of shared co-authors 0
Eneida R Nemecek
Oregon Health Sciences University
Career Start Year 2002
Number of shared co-authors 0
Ivan Pasic
Princess Margaret Cancer Centre
Career Start Year 2001
Number of shared co-authors 1
Sophie Paczesny
Hollings Cancer Center, Medical University of South Carolina
Career Start Year 2001
Number of shared co-authors 0
Bruno C Medeiros
AbbVie Inc.
Career Start Year 1996
Number of shared co-authors 2
Leslie Lehmann
Dana Farber Cancer Institute/Boston Children's Hospital
Career Start Year 1996
Number of shared co-authors 0
Adetola A Kassim
Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 0
Gabrielle Meyers
Oregon Health and Science University
Career Start Year 1994
Number of shared co-authors 0
Paul L Martin
Duke University Medical Center
Career Start Year 1990
Number of shared co-authors 1
Peter Westervelt
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 1
Koen van Besien
University Hospitals of Cleveland
Career Start Year 1988
Number of shared co-authors 2
Clayton A Smith
University of Colorado, Aurora CO.
Career Start Year 1987
Number of shared co-authors 1
Steven Z Pavletic
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1987
Number of shared co-authors 2
Robert H Collins
University of Texas Southwestern Medical Center
Career Start Year 1987
Number of shared co-authors 2
Richard J Jones
Sidney Kimmel Cancer Center, Johns Hopkins University
Career Start Year 1986
Number of shared co-authors 1
Alan S Wayne
Cancer and Blood Disease Institute, Children's Hospital Los Angeles
Career Start Year 1986
Number of shared co-authors 0
Denis-Claude Roy
Universite de Montreal
Career Start Year 1985
Number of shared co-authors 0
Richard T Maziarz
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 2
Dietger Niederwieser
University of Leipzig
Career Start Year 1982
Number of shared co-authors 1
John F DiPersio
Washington University School of Medicine
Career Start Year 1978
Number of shared co-authors 3

Collaborators

Martin S Tallman
Memorial Sloan-Kettering Cancer Center
Co-authored papers 3
Lee W Jones
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Jessica A Lavery
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Heiko Sch??der
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Joshua Bliss
Department of Pharmaceutical Sciences, St Johns University
Co-authored papers 1
Whitney P Underwood
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Jessica M Scott
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Rimma Belenkaya
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Daniel W Kelly
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Su S Chun
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Travis J Hollmann
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Daniel J Henning
University of Washington
Co-authored papers 1
Stacie Corcoran
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
David A Rizzieri
Duke University Medical Center
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Kelly L Bolton
Washington University School of Medicine
Co-authored papers 1
Catherine P Lee
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Fernanda Polubriaginof
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Fei Teng
Ningbo First Hospital
Co-authored papers 1
Chaya S Moskowitz
Memorial Sloan Kettering Cancer Center.
Co-authored papers 1
Gina A Fickera
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Release 1.2